Publications by authors named "Mark L Gonzalgo"

Claim this Profile
P
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer.
Sam S Chang, Karim Chamie, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Sam S Chang, Karim Chamie, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Sam S Chang, Karim Chamie, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Omri Nativ, Mark L Gonzalgo

J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry.
Margaret F Meagher, Zhenjie Wu, Antonio Franco, Linhui Wang, Vitaly Margulis, Mark L Gonzalgo

World J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance Trial.
Pedro F S Freitas, Archan Khandekar, Joao G Porto, Hui Yu, Adam D Williams, Mark L Gonzalgo

J Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Pedro F S Freitas, Archan Khandekar, Joao G Porto, Hui Yu, Adam D Williams, Mark L Gonzalgo

J Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registry.
Francesco Ditonno, Alessandro Veccia, Gabriele Bignante, Zhenjie Wu, Linhui Wang, Mark L Gonzalgo

World J Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node status.
Farshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, Antonio Franco, Zhenjie Wu, Mark L Gonzalgo

Urol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Complication and Readmission Rates Between Robot-Assisted and Open Radical Cystectomy: Results From the Randomized RAZOR Clinical Trial.
Vivek Venkatramani, Isildinha M Reis, Mark L Gonzalgo, Sanjaya Swain, Robert S Svatek

J Urol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative smoking exposure impacts oncologic outcomes of upper tract urothelial carcinoma.
Raj Bhanvadia, Emily Bochner, Benjamin Popokh, Jacob Taylor, Antonio Franco, Mark L Gonzalgo

Urol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective analysis of ureteral stenting during radical cystectomy and ileal conduit urinary diversion: Paediatric feeding tubes versus single-J stents.
Jonathan T Ryan, Tarek Ajami, Adam Williams, Dinno Mendiola, Bruno Nahar, Mark L Gonzalgo

BJUI Compass· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Insights into Upper Tract Urothelial Carcinoma: Lessons Learned from the ROBUUST Collaborative Study.
Arianna Biasatti, Gabriele Bignante, Francesco Ditonno, Alessandro Veccia, Riccardo Bertolo, Mark L Gonzalgo

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression.
Isabella M Kimbel, Veronica Wallaengen, Evangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, Mark L Gonzalgo

Acad Radiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group).
Ahmed Eraky, Reuben Ben-David, Gabriele Bignante, Zhenjie Wu, Linhui Wang, Mark L Gonzalgo

World J Urol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single bladder instillation of gemcitabine versus mitomycin C after minimally invasive radical nephroureterectomy: A propensity-score match analysis from the ROBUUST 2.0 collaborative group.
Eugenio Bologna, Zhenjie Wu, Antonio Franco, Firas Abdollah, Marco Finati, Mark L Gonzalgo

Asian J Urol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes and Recurrence Patterns Following Focal High-intensity Focused Ultrasound Treatment for Localized Prostate Cancer: Insights on Patient Selection and Lessons Learned.
Bruno Nahar, Tarek Ajami, Adam Williams, Nachiketh Soodana Prakash, Archan Khandekar, Mark L Gonzalgo

Eur Urol Focus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomes.
Dhruv Puri, Margaret F Meagher, Zhenjie Wu, Antonio Franco, Linhui Wang, Mark L Gonzalgo

BJU Int· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial.
Tarek Ajami, Hui Yu, Joao G Porto, Nachiketh Soodana Prakash, Adam Williams, Mark L Gonzalgo

Eur Urol Focus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of biochemical and imaging criteria for selecting patients for prostate biopsy in recurrence risk assessment post-HIFU therapy.
Tarek Ajami, Adam Williams, Jonathan T Ryan, Nachiketh Soodana Prakash, Archan Khandekar, Mark L Gonzalgo

World J Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of BMI Category on Recurrence and Progression of Nonmuscle Invasive Bladder Cancer Prognosis.
Jamie Thomas, Aakangsha Jain, Ram Hirpara, Ruben Blachman-Braun, Helen Y Hougen, Mark L Gonzalgo

Clin Genitourin Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group).
Francesco Ditonno, Antonio Franco, Eugenio Bologna, Alessandro Veccia, Riccardo Bertolo, Mark L Gonzalgo

Minerva Urol Nephrol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of warm ischemia time measurement using a surgical intelligence software in partial nephrectomies: A validation study.
Archan Khandekar, Joao G Porto, Jean C Daher, Pedro F S Freitas, Dotan Asselman, Mark L Gonzalgo

BJUI Compass· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry.
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, Zhenjie Wu, Linhui Wang, Mark L Gonzalgo

World J Urol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry.
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, Zhenjie Wu, Linhui Wang, Mark L Gonzalgo

World J Urol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis